A detailed history of Eisler Capital (Uk) Ltd. transactions in Pfizer Inc stock. As of the latest transaction made, Eisler Capital (Uk) Ltd. holds 27,854 shares of PFE stock, worth $690,779. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,854
Previous 22,225 25.33%
Holding current value
$690,779
Previous $621,000 29.79%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $155,923 - $176,694
5,629 Added 25.33%
27,854 $806,000
Q2 2024

Aug 13, 2024

BUY
$25.26 - $29.6 $79,265 - $92,884
3,138 Added 16.44%
22,225 $621,000
Q1 2024

May 14, 2024

SELL
$25.89 - $29.73 $2.66 Million - $3.05 Million
-102,554 Reduced 84.31%
19,087 $529,000
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $2.58 Million - $3.35 Million
98,633 Added 428.69%
121,641 $3.5 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $738,326 - $863,030
23,008 New
23,008 $763,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $139B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Eisler Capital (Uk) Ltd. Portfolio

Follow Eisler Capital (Uk) Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eisler Capital (Uk) Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Eisler Capital (Uk) Ltd. with notifications on news.